Regulation
FDA expands approval of Instylla’s Embrace HES for arterial bleeds
The FDA has expanded clearance for Instylla's Embrace HES hemostatic system to treat peripheral arterial bleeds in vessels up to 6mm in diameter. The expanded indication broadens the device's use in managing arterial hemorrhage beyond its previous scope.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network